Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Condition(s):Head and Neck Cancer; Oral LeukoplakiaLast Updated:February 11, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Head and Neck Cancer; Oral LeukoplakiaLast Updated:February 11, 2022Completed
Condition(s):Oral Leukoplakia; Oral Leukoplakia of Tongue; Oral Leukoplakia of Gingiva; Oral Lichen PlanusLast Updated:December 3, 2019Recruiting
Condition(s):Oral LeukoplakiaLast Updated:January 17, 2024Not yet recruiting
Condition(s):Oral LeukoplakiaLast Updated:February 21, 2024Not yet recruiting
Condition(s):Erythroplakia; Oral LeukoplakiaLast Updated:March 30, 2023Recruiting
Condition(s):Leukoplakia, Oral; Benign NeoplasmsLast Updated:November 19, 2020Completed
Condition(s):Leukoplakic LesionsLast Updated:July 28, 2017Completed
Condition(s):Lip and Oral Cavity Cancer; Oral Leukoplakia; Oropharyngeal Cancer; Tongue CancerLast Updated:December 19, 2014Completed
Condition(s):Oral LeukoplakiaLast Updated:April 6, 2016Terminated
Condition(s):Head and Neck Cancer; Precancerous ConditionLast Updated:July 11, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.